CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $24.68M, above the global median of $18.73M
- FinancialsAltman Z-Score 3.92: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.42%
Annual Rate
CNY 0.06Paid annual
Payout Ratio
283.3%High
Last Ex-Dividend
Jun 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.82BCNY868.40M · vs all stocks (USD)
Trailing P/E
102.25xRevenue (TTM)
1.56BCNY233.00M · vs all stocks (USD)
Profit Margin
0.02%Beta
0.9950xvs all stocks
52-Week Change
13.41%vs all stocks
Market Capitalization
5.82BCNY868.40M · vs all stocks (USD)
Enterprise Value
6.21BCNY927.39M · vs all stocks (USD)
Trailing P/E
102.25xForward P/E
13.44xPrice to Sales (TTM)
3.72xPrice to Book (MRQ)
3.97xEnterprise to Revenue
3.98xEnterprise to EBITDA
29.81xGross Margin
70.10%Profit Margin
0.02%Operating Margin
-6.12%Return on Assets (TTM)
3.17%Return on Equity (TTM)
0.04%Revenue (TTM)
1.56BCNY233.00M · vs all stocks (USD)
Revenue per Share (TTM)
3.72CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-39.40%Gross Profit (TTM)
1.11BCNY165.32M · vs all stocks (USD)
EBITDA (TTM)
277.06MCNY41.37M · vs all stocks (USD)
Net Income (TTM)
374.22KCNY55.88K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-56.54%Operating Cash Flow (TTM)
258.60MCNY38.62M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
165.29MCNY24.68M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0600CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.42%vs all stocks
Payout Ratio
283.33%Minority Interest (Equity)
66.63MCNYFY2025 · Dec 31, 2025Revenue
1.70BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
511.49MCNYFY2025 · Dec 31, 2025Gross Profit
1.19BCNYFY2025 · Dec 31, 2025Operating Income
198.70MCNY29.67M · vs all stocks (USD)
Pre-tax Income
67.77MCNYFY2025 · Dec 31, 2025Income Tax Expense
19.61MCNYFY2025 · Dec 31, 2025Net Income
48.15MCNYFY2025 · Dec 31, 2025EBIT
78.84MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
277.06MCNYFY2025 · Dec 31, 2025Research & Development
27.91MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
646.17MCNYFY2025 · Dec 31, 2025Other Operating Expenses
26.81MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.96MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
11.07MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1100CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
420.49MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
420.49MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
48.15MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.90MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
358.51MCNYFY2025 · Dec 31, 2025Free Cash Flow
333.32MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
389.42MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
48.15MCNYFY2025 · Dec 31, 2025Other Non-cash Items
25.62MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
196.23MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
88.51MCNYFY2025 · Dec 31, 2025Capital Expenditures
-25.20MCNYFY2025 · Dec 31, 2025Purchase of Investments
-206.83MCNYFY2025 · Dec 31, 2025Sale of Investments
657.84KCNYFY2025 · Dec 31, 2025Other Investing Activity
2.94MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-228.44MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
570.54MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-418.91MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-161.44MCNYFY2025 · Dec 31, 2025Other Financing Charges
-11.76MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-21.57MCNYFY2025 · Dec 31, 2025Shares Outstanding
408.93MSharesUpdated Sep 22, 2026Float Shares
181.55MSharesUpdated Sep 22, 2026% Held by Insiders
59.38%vs all stocks
% Held by Institutions
2.52%vs all stocks
Total Cash (MRQ)
313.45MCNY46.81M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7740CNYUpdated Sep 22, 2026Total Debt (MRQ)
636.69MCNY95.08M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4150xCurrent Ratio (MRQ)
1.71xBook Value per Share (MRQ)
3.63CNYUpdated Sep 22, 2026Total Assets
2.85BCNY425.28M · vs all stocks (USD)
Total Current Assets
1.53BCNYFY2025 · Dec 31, 2025Total Liabilities
1.34BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.32BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
298.52MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.04BCNYFY2025 · Dec 31, 2025Cash
389.39MCNYFY2025 · Dec 31, 2025Cash Equivalents
30.33KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
389.42MCNYFY2025 · Dec 31, 2025Other Short-term Investments
19.93MCNYFY2025 · Dec 31, 2025Accounts Receivable
590.39MCNYFY2025 · Dec 31, 2025Inventory
222.42MCNYFY2025 · Dec 31, 2025Accounts Payable
112.29MCNYFY2025 · Dec 31, 2025Short-term Debt
608.57MCNYFY2025 · Dec 31, 2025Other Current Liabilities
18.36MCNYFY2025 · Dec 31, 2025Long-term Debt
149.75MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
80.11MCNYFY2025 · Dec 31, 2025Common Stock (Book)
408.93MCNYFY2025 · Dec 31, 2025Retained Earnings
832.46MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.51BCNY225.82M · vs all stocks (USD)
Treasury Stock
94.35MCNYFY2025 · Dec 31, 202552-Week Low
9.51CNYUpdated Sep 22, 202652-Week High
17.46CNYUpdated Sep 22, 202652-Week Change
13.41%vs all stocks
Beta
0.9950xvs all stocks
50-Day MA
11.82CNYUpdated Sep 22, 2026200-Day MA
12.22CNYUpdated Sep 22, 2026Avg 10-Day Volume
32.31MSharesUpdated Sep 22, 2026Avg 30-Day Volume
21.02MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.1100CNYUpdated Sep 22, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.70Profit Margin: 0.00
Financial Health
Altman Z-Score 3.92: safe zoneNotable
Altman Z-Score: 3.92
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $24.68M, above the global median of $18.73MNotable
Levered free cash flow (USD): 24,682,521.551Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Shouyao Holdings Beijing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Keqian Biology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hpgc Renmintongtai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chongqing Pharscin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wanbangde Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing SL Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hangzhou Bio-Sincerity Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sana Biotechnology, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Ardelyx Inc.
Tier 1ProductionApproval-Gated PipelineRule
Theravance Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule